Cardiomyogenic Potential of Human Adult Bone Marrow Mesenchymal Stem Cells in Vitro

Abstract

Background: The aim of this study was to investigate the ability of adult human bone marrow mesenchymal stem cells to differentiate towards a cardiomyogenic phenotype in vitro. Methods: Bone marrow samples were aspirated from 30 patients undergoing open heart surgery from the anterior iliac crest. Second passaged cells were treated with 10 µM 5-azacytidine. As control groups we used cells not expanded in culture and cells untreated with 5-azacytidine. Morphologic characteristics were analysed by confocal and electron microscopy. The expression of the cytoskeletal protein vimentin and muscle-specific myocin heavy chain was analysed by immunohistochemistry. The expression of the cardiomyocyte specific genes α-cardiac actin, beta-myocin heavy chain and cardiac troponin-T was detected by reverse transcriptase polymerase chain reaction. Results: Mesenchymal stem cells were spindle-shaped with irregular processes. Cells treated with 5-azacytidine assumed a stick-like morphology. They connected with adjoining cells to form myotube-like structures. Numerous myofilaments were detected in induced cells which were immunohistochemically positive for myosin heavy chain and vimentin. The mRNAs of all specific cardiac genes were expressed in both induced and uninduced cells. Conclusion: These results indicate that adult human bone marrow mesenchymal stem cells treated with 5-aza can differentiate towards a cardiomyogenic lineage in vitro.

cardiovascular surgery - heart disease - cardiomyopathy

References

• 1 Siepe M, Heilman C, von Samson P, Menasche P, Beyersdorf F. Stem cell research and cell transplantation for myocardial regeneration.  Eur J Cardiothor Surg. 2005;  28 318-324
• 2 Pittenger M F, Mackay A M, Beck S C. et al . Multilineage potential of adult human mesenchymal stem cells.  Science. 1999;  284 143-147
• 3 Kocher A A, Schuster M D, Szabolcs M J. et al . Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.  Nat Med. 2001;  7 430-436
• 4 Bittira B, Kuang J Q, Al-Khaldi A, Shum-Tim D, Chiu R C. In vitro preprogramming of marrow stromal cells for myocardial regeneration.  Ann Thorac Surg. 2002;  74 1154-1160
• 5 Heng B C, Haider H K, Sim E, Cao T, Ng S C. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro.  Cardiov Res. 2004;  62 34-42
• 6 Makino S, Fukuda K, Miyoshi S. et al . Cardiomyocytes can be generated from marrow stromal cells in vitro.  J Clin Invest. 1999;  103 697-705
• 7 Rangappa S, Entwistle J W, Wechsler A S, Kresh J Y. Cardiomyocyte-mediated conact programs human mesenchymal stem cells to express cardiogenic phenotype.  J Thorac Cardiovasc Surg. 2003;  126 124-132
• 8 Dimarakis I, Habib H A, Gordon M. Adult bone marrow-derived stem cells and the injured heart: just the beginning?.  Eur J Cardiothor Surg. 2005;  28 665-676
• 9 Pittenger M F, Martin B J. Mesenchymal stem cells and their potential as cardiac therapeutics.  Circ Res. 2004;  95 9-20
• 10 Wakitani S, Saito T, Caplan A I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.  Muscle Nerve. 1995;  18 1417-1426
• 11 Goldsborough M D, Tilkins M L, Price P J. Serum-free culture of murine embryonic stem (ES) cells.  Focus. 1998;  20 8-12
• 12 Shim W S, Jiang S, Wong P. et al . Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells.  Bioch Biophys Res Commun. 2004;  324 481-488
• 13 Planat-Benard V, Menard C, Andre M. et al . Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells.  Circ Res. 2004;  94 223-229
• 14 Liu Y, Song J, Liu W, Wan Y, Chen X, Hu C. Growth and differentiation of rat bone marrow stromal cells: can 5-azacytidine trigger their cardiomyogenic differentiation?.  Cardiov Res. 2003;  58 460-468
• 15 Raimondo S, Penna C, Pagliaro P, Geuna S. Morphological characterization of GFP stably transfected adult mesenchymal bone marrow stem cells.  J Anat. 2006;  208 3-12
• 16 Takayama K T, Inoue T, Ijiri Y. et al . Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells.  Bioch Biophys Res Commun. 2004;  323 86-90
• 17 Tomita S, Li R K, Weisel R. et al . Autologous transplantation of bone marrow cells improves damaged heart function.  Circulation. 1999;  100 (Suppl II) 247-256
• 18 Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering.  Artif Organs. 2001;  25 187-193
• 19 Xu W, Zhang X, Qian H. et al . Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro.  Exp Biol Med. 2004;  229 623-631
• 20 Bayes-Genis A, Roura S, Soler-Botija C. et al . Identification of cardiomyogenic lineage markers in untreated human bone marrow-derived mesenchymal stem cells.  Transplant Proc. 2005;  37 4077-4099
• 21 Seshi B, Kumar S, King D. Multilineage gene expression in human bone marrow stromal cells as evidenced by single-cell microarray analysis.  Blood Cells Mol Dis. 2003;  33 268-285
• 22 Jiang Y, Jahagirdar B N, Reinhardt R L. et al . Pluripotency of mesenchymal stem cells derived from adult bone marrow.  Nature. 2002;  418 41-49
• 23 Ye N S, Zhang R L, Zhao Y F, Feng X, Wang Y M, Luo G A. Effect of 5-azacytidine on the protein expression of porcine bone marrow mesenchymal stem cells in vitro.  Geno Prot Bioinfo. 2006;  4 18-25